Barclays, Citi, HSBC and National Australia Bank have provided a $20m extension, joining a round already backed by CreditEase and American Express Ventures.
Israel-based behavioural biometrics technology provider BioCatch grew its series C round to $168m yesterday following a $20m extension backed by financial services firms Barclays, Citi, HSBC and National Australia Bank (NAB).
BioCatch received an initial $145m tranche in April 2020 when online lending platform CreditEase and American Express Ventures, the investment arm of payment services firm American Express, both invested.
Bain Capital Tech Opportunities, a growth equity arm for private equity firm Bain Capital, led the first close, while…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
